PHARMACOLOGY AND PHARMACOKINETICS OF ENOXIMONE

被引：23

作者：

DAGE, RC ^{[1
]}

OKERHOLM, RA ^{[1
]}

机构：

[1] MERRELL DOW PHARMACEUT INC,DEPT DRUG METAB,CINCINNATI,OH 45215

来源：

CARDIOLOGY | 1990年 / 77卷

关键词：

D O I：

10.1159/000174664

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2 / 13

页数：12

共 18 条

[1] KINETICS OF FENOXIMONE, A NEW CARDIOTONIC, IN HEALTHY-SUBJECTS [J].

ALKEN, RG ;

BELZ, GG ;

HAEGELE, KD ;

MEINICKE, T ;

SCHECHTER, PJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (02) :209-216

[2]

APPLEMAN MM, 1984, ADV CYCLIC NUCLEOTID, V16, pR6

[3] QUANTITATIVE-DETERMINATION OF CARDIOTONIC AGENT MDL 17,043 IN PLASMA BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].

CHAN, KY ;

LANG, JF ;

OKERHOLM, RA .

JOURNAL OF CHROMATOGRAPHY, 1983, 272 (02) :396-400

[4] SIMULTANEOUS ANALYSIS OF A NEW CARDIOTONIC AGENT, MDL-17,043, AND ITS MAJOR SULFOXIDE METABOLITE IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].

CHAN, KY ;

OHLWEILER, DF ;

LANG, JF ;

OKERHOLM, RA .

JOURNAL OF CHROMATOGRAPHY, 1984, 306 (MAR) :249-256

[5] CARDIOVASCULAR PROPERTIES OF A NEW CARDIOTONIC AGENT - MDL 17,043 (1,3-DIHYDRO-4-METHYL-5-[4-(METHYLTHIO)-BENZOYL]-2H-IMIDAZOL-2-ONE) [J].

DAGE, RC ;

ROEBEL, LE ;

HSIEH, CP ;

WEINER, DL ;

WOODWARD, JK .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 (03) :500-508

[6]

DAGE RC, 1987, AM J CARDIOL, V60, pC10

[7]

ENDOH M, 1985, J PHARMACOL EXP THER, V234, P267

[8]

HARRISON SA, 1986, MOL PHARMACOL, V29, P506

[9] EFFECTS OF ENOXIMONE AND ISOBUTYLMETHYLXANTHINE ON CONTRACTILE TENSION AND CYCLIC-NUCLEOTIDE LEVELS IN ISOLATED BLOOD-PERFUSED DOG PAPILLARY-MUSCLE [J].

HSIEH, CP ;

KARIYA, T ;

DAGE, RC ;

RUBERG, SJ .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 9 (02) :230-236

[10] TISSUE DISTRIBUTION AND SELECTIVE-INHIBITION OF SUBTYPES OF HIGH-AFFINITY CAMP PHOSPHODIESTERASE [J].

KARIYA, T ;

DAGE, RC .

BIOCHEMICAL PHARMACOLOGY, 1988, 37 (17) :3267-3270

← 1 2 →